STOCK TITAN

Medtronic (NYSE: MDT) EVP Kweli details shares, options and PSU holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Medtronic plc EVP & President, Neuroscience Thompson Kweli filed an initial Form 3 showing his current equity holdings in the company. He directly owns 30,017.737 ordinary shares and holds multiple stock option grants with varying exercise prices and expirations, plus performance share units that may convert into additional shares based on future vesting and performance conditions.

Positive

  • None.

Negative

  • None.
Insider Thompson Kweli
Role EVP & President, Neuroscience
Type Security Shares Price Value
holding Performance Share Unit -- -- --
holding Performance Share Units -- -- --
holding Performance Share Units -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Performance Share Unit — 3,252.987 shares (Direct, null); Performance Share Units — 9,911.187 shares (Direct, null); Stock Option (Right to Buy) — 1,704 shares (Direct, null); Ordinary Shares — 30,017.737 shares (Direct, null)
Footnotes (1)
  1. Includes 6,549 performance stock units that vested on April 24, 2026; 1,822 restricted stock units that vested on December 6, 2025; 3,742.990 restricted stock units that vest on July 31, 2026; 3,402.644 restricted stock units that vest on December 6, 2026; 9,911.187 restricted stock units that vest on July 29, 2027; 4,589.916 restricted stock units that vest on July 28, 2028. The performance share units ("PSUs") vest on December 6, 2026. The number of shares to be issued in connection with the PSUs reported reflects the amount earned based on achievement of applicable performance criteria. The award remains subject to time-based vesting. Each PSU represents a contingent right to receive one share of Medtronic common stock. The PSUs vest on April 30, 2027. The number of shares to be issued in connection with PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,911.187 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. The PSUs vest on April 28, 2028. The number of shares to be issued in connection with the PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,178.809 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Direct ordinary share holdings 30,017.737 shares Directly owned Medtronic ordinary shares reported on Form 3
Option grant at $91.97 22,363 underlying shares at $91.97 Stock option (right to buy), expires July 28, 2035
Option grant at $87.76 25,408 underlying shares at $87.76 Stock option (right to buy), expires July 31, 2033
Option grant at $93.08 26,890 underlying shares at $93.08 Stock option (right to buy), expires August 1, 2032
Performance share units 2027 target 9,911.187 shares Target shares from PSUs vesting July 29, 2027 if metrics met
Performance share units 2028 target 9,178.809 shares Target shares from PSUs vesting April 28, 2028 if metrics met
PSU vesting date December 6, 2026 One PSU award vests on this date per footnotes
RSUs vesting July 31, 2026 3,742.990 units Restricted stock units scheduled to vest on July 31, 2026
Performance Share Units financial
"The performance share units ("PSUs") vest on December 6, 2026."
Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.
restricted stock units financial
"restricted stock units that vest on July 31, 2026; 3,402.644 restricted stock units that vest on December 6, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option (right to buy financial
"Stock Option (Right to Buy) with various exercise prices and expiration dates"
exercise price financial
"The number of shares to be issued in connection with the PSUs will vary depending on the level of certain performance metrics achieved"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The award remains subject to time-based vesting."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
performance metrics financial
"will vary depending on the level of certain performance metrics achieved over a three (3) year performance period."
Performance metrics are concrete numbers or ratios that show how well a business, product, or investment is doing—like speed, fuel use and mileage on a car’s dashboard. They measure things investors care about, such as sales growth, profitability, cash flow, customer retention or efficiency, so readers can compare progress, spot strengths or problems, and make informed decisions about buying, holding or selling shares.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Thompson Kweli

(Last)(First)(Middle)
710 MEDTRONIC PARKWAY

(Street)
MINNEAPOLIS MINNESOTA 55432

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
06/18/2026
3. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & President, Neuroscience
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares30,017.737(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Share Unit (2) (2)Ordinary Shares3,252.987(3)(4)D
Performance Share Units (5) (5)Ordinary Shares9,911.187(6)(4)D
Performance Share Units (7) (7)Ordinary Shares9,178.809(8)(4)D
Stock Option (Right to Buy)08/01/2017(9)08/01/2026Ordinary Shares1,704$88.06D
Stock Option (Right to Buy)01/30/2018(9)01/30/2027Ordinary Shares1,608$74.67D
Stock Option (Right to Buy)07/31/2018(9)07/31/2027Ordinary Shares4,407$83.97D
Stock Option (Right to Buy)07/30/2019(9)07/30/2028Ordinary Shares6,271$89.08D
Stock Option (Right to Buy)07/29/2020(9)07/29/2029Ordinary Shares1,615$103.26D
Stock Option (Right to Buy)08/03/2021(9)08/03/2030Ordinary Shares10,181$97.33D
Stock Option (Right to Buy)08/02/2022(9)08/02/2031Ordinary Shares6,358$131.26D
Stock Option (Right to Buy)08/01/2023(9)08/01/2032Ordinary Shares26,890$93.08D
Stock Option (Right to Buy)07/31/2024(9)07/31/2033Ordinary Shares25,408$87.76D
Stock Option (Right to Buy)07/29/2025(9)07/29/2034Ordinary Shares1,540$80D
Stock Option (Right to Buy)07/28/2026(9)07/28/2035Ordinary Shares22,363$91.97D
Explanation of Responses:
1. Includes 6,549 performance stock units that vested on April 24, 2026; 1,822 restricted stock units that vested on December 6, 2025; 3,742.990 restricted stock units that vest on July 31, 2026; 3,402.644 restricted stock units that vest on December 6, 2026; 9,911.187 restricted stock units that vest on July 29, 2027; 4,589.916 restricted stock units that vest on July 28, 2028.
2. The performance share units ("PSUs") vest on December 6, 2026.
3. The number of shares to be issued in connection with the PSUs reported reflects the amount earned based on achievement of applicable performance criteria. The award remains subject to time-based vesting.
4. Each PSU represents a contingent right to receive one share of Medtronic common stock.
5. The PSUs vest on April 30, 2027.
6. The number of shares to be issued in connection with PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,911.187 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
7. The PSUs vest on April 28, 2028.
8. The number of shares to be issued in connection with the PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,178.809 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
9. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact06/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)